Blinding in clinical trials and other studies
Simon Day and Doug Altman discuss blinding in clinical trials.Key Concepts addressed:
Human behaviour is influenced by what we know or believe. In research there is a particular risk of expectation influencing findings, most obviously when there is some subjectivity in assessment, leading to biased results. Blinding (sometimes called masking) is used to try to eliminate such bias.